12 unknown, 9 completed, 7 recruiting, 3 active not recruiting. 14 Phase 1, 13 Phase 2, 4 Early Phase 1, 4 Not applicable.
Follow Cell Count: new trials by email Literature Review of Cell Count trials Research Report on Cell Count
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Small Mobile Stem Cells (SMS) in Moderate to Severe Chronic Obstructive Pulmonary Disease Stem cells - Chronic Obstructive Lung Disease | Phase 1 / Phase 2 | Not yet recruiting | SMSbiotech | 125 | 2026-10-01 | 2026-10-13 |
| Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection Autologous Cytokine-Induced Killer (CIK) Cells - Hepatocellular Carcinoma (HCC) | Early Phase 1 | Not yet recruiting | Royan Institute | 6 | 2026-07-01 | 2026-07-16 |
| Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS) Nogapendekin Alfa-Inbakicept (NAI), Allogeneic invariant Natural Killer T (iNKT) Cells (AgenT-797) - Acute Respiratory Distress Syndrome, Severe Community-Acquired Pneum | Phase 2 | Withdrawn | ImmunityBio, Inc. | 2026-04-15 | 2026-05-08 | |
| WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC Whole Agonist-Stimulated T (WAST) cells injection, Docetaxel - NSCLC (Non-small Cell Lung Cancer) | Phase 2 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 31 | 2025-12-01 | 2026-01-09 |
| Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD). Stem cells - Chronic Obstructive Lung Disease | Phase 1 | Recruiting | SMSbiotech | 18 | 2025-06-13 | 2026-08-11 |
| R-MVST Cells for Treatment of Viral Infections in Children and Young Adults Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus, Cytomegalovirus Infections | Phase 1 | Recruiting | Monica Bhatia | 18 | 2025-04-20 | 2026-07-30 |
| Allogeneic γδT Cells in Glioblastoma Allogeneic γδ T (ABOUT) cells - Glioblastoma (GBM), Glioblastoma Multiforme (GBM) | Not applicable | Recruiting | Peking University Third Hospital | 18 | 2025-04-01 | 2025-08-27 |
| Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma Cytokine Induced Memory-like Natural Killer (CIML NK) Cells, Interleukin-2 (IL-2) - Renal Carcinoma, Renal Cell Carcinoma | Early Phase 1 | Active not recruiting | Dana-Farber Cancer Institute | 5 | 2024-08-28 | 2026-10-23 |
| Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells, Implantation, Magnetic Resonance Imaging (MRI) - Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor | Phase 1 | Suspended | Sabine Mueller, MD, PhD | 24 | 2024-05-31 | 2026-04-24 |
| Lipid Balance in Adult Sickle Cell Patients HDL2 - Sickle Cell Disease, Dyslipidemia | Not applicable | Active not recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 116 | 2022-11-30 | 2025-12-10 |
| AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer AB-1015 - Carcinoma, Ovarian Epithelial, Ovarian Neoplasms | Phase 1 | Active not recruiting | Arsenal Biosciences, Inc. | 19 | 2022-11-29 | 2026-09-03 |
| Clinical Trial of Infusion of Activated NK Cells for the Treatment of Sarcomas Natural Killer (NK) cells (a new immunotherapy) - Malignant Sarcoma | Not applicable | Recruiting | Antonio Pérez Martínez | 10 | 2022-10-24 | 2023-07-21 |
| R-MVST Cells for Treatment of Viral Infections Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus Infections, Cytomegalovirus Infections | Phase 1 | Recruiting | Columbia University | 36 | 2022-05-03 | 2026-06-10 |
| Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells, Human Embryonic Stem Cell-Derived Cardiomyocyte 150 cells, Human Embryonic Stem Cell-Derived Cardiomyocyte 300M cells - Chronic Ischemic Left Ventricular Dysfunction | Phase 1 | Recruiting | Joseph C. Wu | 18 | 2022-03-22 | 2025-09-29 |
| Assessment of Vulnerability to Carotid Stenosis by MultiModal Imaging and Cellular and Molecular Biology Analysis Data collection, collection of the carotid plaque (surgical specimen), anatomopathological, histological, cellular and molecular biology examinations (metabolomics and transcriptomics) on surgical specimens - Internal Carotid Artery, Atheromatous Stenosis | Terminated | Centre Hospitalier Universitaire Dijon | 12 | 2022-02-14 | 2024-07-30 | |
| NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer NKG2D CAR-NK - Refractory Metastatic Colorectal Cancer | Phase 1 | Unknown | Zhejiang University | 38 | 2021-12-10 | 2024-02-12 |
| Precision Diagnostics of Functional and Organic Intestinal Pathology Based on Cellular and Molecular Profiling cell and molecular diagnostics in accordance with functional test results - Inflammatory Bowel Diseases, Irritable Bowel Syndrome | Not applicable | Unknown | Moscow State University of Medicine and Dentistry | 120 | 2021-10-01 | 2022-03-14 |
| NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer CAR-T infusion - Refractory Metastatic Colorectal Cancer | Early Phase 1 | Unknown | The Third Affiliated Hospital of Guangzhou Medical University | 9 | 2021-09-13 | 2022-02-21 |
| Immunity After COVID-19 Vaccination Cellular and antibody response to spike antigens of SARS-CoV-2 in both groups in peripheral blood samples - Immunity to COVID-19 | Unknown | Plexision | 300 | 2021-04-27 | 2021-05-12 | |
| Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia Posoleucel (formerly known as ALVR105) cells, Placebo (visually identical to Posoleucel) - BK Virus Nephropathy, BK Virus Infection | Phase 2 | Completed | AlloVir | 61 | 2021-03-22 | 2024-05-16 |
Showing 20 of 38. Sign in to see all of them.
Adenoviridae Infections (2) · Colorectal Neoplasms (2) · Community-Acquired Pneumonia (2) · Cytomegalovirus Infections (2) · Diabetic Foot (2) · Epstein-Barr Virus Infections (2) · Immunologic Deficiency Syndromes (2) · Leukemia, Myeloid, Acute (2) · Multiple Myeloma (2) · Myelodysplastic Syndromes (2) · Pulmonary Disease, Chronic Obstructive (2) · Varicose Ulcer (2) · Wounds and Injuries (2) · Abdominal Neoplasms (1) · Acquired Immunodeficiency Syndrome (1)
U.S. Wound Registry (3) · SMSbiotech (2) · A.O. Ospedale Papa Giovanni XXIII (1) · AlloVir (1) · Altor BioScience (1) · Antonio Pérez Martínez (1) · Arsenal Biosciences, Inc. (1) · Azidus Brasil (1) · Brenda Cooper, MD (1) · Centre Hospitalier Universitaire Dijon (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · Columbia University (1) · Dana-Farber Cancer Institute (1) · Eyecure Therapeutics Inc. (1) · Fujian Cancer Hospital (1)
United States (19) · China (7) · France (2) · Australia (1) · Brazil (1) · Guadeloupe (1) · Iran (1) · Italy (1) · Russia (1) · South Korea (1) · Spain (1)
Alessandro AR Rambaldi, Professor (1) · Arsenal Biosciences (1) · Ashok Reddy, BE (1) · Charles S Cox, MD (1) · David Wald, MD, PhD (1) · Erica Warlick, M.D. (1) · Frits van Rhee, MD, PhD (1) · Hing C Wong, PhD (1) · Igor Maev, Acad.the RAS (1)
PMID 16980990, PMID 17606446, PMID 19462317, PMID 20685246, PMID 26400297, PMID 26507860, PMID 30429586, PMID 32294476, PMID 32330874, PMID 33189181, PMID 33558725, PMID 33773631, PMID 35626701, PMID 38207119, PMID 38597860, PMID 38734138, PMID 39382091, PMID 40770775